A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion

Vaccines are considered as a therapeutic area for children; the scientific community focuses mainly on managing chronic disease when it comes to adults. There currently is an increase in the burden of vaccine preventable illnesses in adults. Adult vaccination has been shown to dramatically increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Reena, Gathu, Catherine, Njenga, Eric, Chakaya, Jeremiah, Ogola, Elijah, Oyoo, Omondi, Odhiambo, Andrew, Wambugu, Benjamin, Feldman, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917456/
https://www.ncbi.nlm.nih.gov/pubmed/35317473
http://dx.doi.org/10.11604/pamj.2022.41.51.31849
_version_ 1784668549236654080
author Shah, Reena
Gathu, Catherine
Njenga, Eric
Chakaya, Jeremiah
Ogola, Elijah
Oyoo, Omondi
Odhiambo, Andrew
Wambugu, Benjamin
Feldman, Charles
author_facet Shah, Reena
Gathu, Catherine
Njenga, Eric
Chakaya, Jeremiah
Ogola, Elijah
Oyoo, Omondi
Odhiambo, Andrew
Wambugu, Benjamin
Feldman, Charles
author_sort Shah, Reena
collection PubMed
description Vaccines are considered as a therapeutic area for children; the scientific community focuses mainly on managing chronic disease when it comes to adults. There currently is an increase in the burden of vaccine preventable illnesses in adults. Adult vaccination has been shown to dramatically increase the health and quality of life of older populations. Therefore, adult vaccinations need to be approached as a public health issue, similar to smoking cessation programs, for example. According to the Kenya Non-Communicable Diseases and injuries poverty commission report, 2018. Kenya has a high percentage of disability adjusted life years (DALYs) from communicable diseases at 63%, while non-communicable diseases (NCDs) contribute 30% of the DALYs. Specific to pneumococcal pneumonia (PP) in adults, the Global burden of disease (GBD) study in 2016 found that 2,377,697 people of all ages died from lower respiratory tract infections (LRTI) in 2016. Of these, more people died from Streptococcus pneumonia(SP) than from all other studied respiratory pathogens combined. While the incidence of LRTIs in children under five years old was reducing, partly as a result of well-established vaccination programs in children, the incidence, morbidity and mortality of PP was increasing in older populations. The expert recommendations included the following; i) all individuals 65 years of age and above, and individuals with a predisposing comorbidity regardless of age, should receive the pneumococcal vaccine; ii) several systemic modules can be emulated from the successful childhood vaccines programs onto an adult vaccine program; iii) formulation of an effective vaccine program will require collaboration from the public, the government, healthcare providers, and the media, to create awareness; iv) stakeholders who need to be involved in vaccine policy development and implementation include medical professional associations, nurses, pharmacists, clinical officers, payers (private and public insurances), government, medical learning institutions and faith-based medical organizations.
format Online
Article
Text
id pubmed-8917456
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-89174562022-03-21 A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion Shah, Reena Gathu, Catherine Njenga, Eric Chakaya, Jeremiah Ogola, Elijah Oyoo, Omondi Odhiambo, Andrew Wambugu, Benjamin Feldman, Charles Pan Afr Med J Opinion Vaccines are considered as a therapeutic area for children; the scientific community focuses mainly on managing chronic disease when it comes to adults. There currently is an increase in the burden of vaccine preventable illnesses in adults. Adult vaccination has been shown to dramatically increase the health and quality of life of older populations. Therefore, adult vaccinations need to be approached as a public health issue, similar to smoking cessation programs, for example. According to the Kenya Non-Communicable Diseases and injuries poverty commission report, 2018. Kenya has a high percentage of disability adjusted life years (DALYs) from communicable diseases at 63%, while non-communicable diseases (NCDs) contribute 30% of the DALYs. Specific to pneumococcal pneumonia (PP) in adults, the Global burden of disease (GBD) study in 2016 found that 2,377,697 people of all ages died from lower respiratory tract infections (LRTI) in 2016. Of these, more people died from Streptococcus pneumonia(SP) than from all other studied respiratory pathogens combined. While the incidence of LRTIs in children under five years old was reducing, partly as a result of well-established vaccination programs in children, the incidence, morbidity and mortality of PP was increasing in older populations. The expert recommendations included the following; i) all individuals 65 years of age and above, and individuals with a predisposing comorbidity regardless of age, should receive the pneumococcal vaccine; ii) several systemic modules can be emulated from the successful childhood vaccines programs onto an adult vaccine program; iii) formulation of an effective vaccine program will require collaboration from the public, the government, healthcare providers, and the media, to create awareness; iv) stakeholders who need to be involved in vaccine policy development and implementation include medical professional associations, nurses, pharmacists, clinical officers, payers (private and public insurances), government, medical learning institutions and faith-based medical organizations. The African Field Epidemiology Network 2022-01-19 /pmc/articles/PMC8917456/ /pubmed/35317473 http://dx.doi.org/10.11604/pamj.2022.41.51.31849 Text en Copyright: Reena Shah et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion
Shah, Reena
Gathu, Catherine
Njenga, Eric
Chakaya, Jeremiah
Ogola, Elijah
Oyoo, Omondi
Odhiambo, Andrew
Wambugu, Benjamin
Feldman, Charles
A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion
title A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion
title_full A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion
title_fullStr A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion
title_full_unstemmed A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion
title_short A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion
title_sort case for implementation of adult pneumococcal vaccine program in africa: review and expert opinion
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917456/
https://www.ncbi.nlm.nih.gov/pubmed/35317473
http://dx.doi.org/10.11604/pamj.2022.41.51.31849
work_keys_str_mv AT shahreena acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT gathucatherine acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT njengaeric acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT chakayajeremiah acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT ogolaelijah acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT oyooomondi acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT odhiamboandrew acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT wambugubenjamin acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT feldmancharles acaseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT shahreena caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT gathucatherine caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT njengaeric caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT chakayajeremiah caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT ogolaelijah caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT oyooomondi caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT odhiamboandrew caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT wambugubenjamin caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion
AT feldmancharles caseforimplementationofadultpneumococcalvaccineprograminafricareviewandexpertopinion